News

Pfizer to Close Facility in Peapack, NJ, Affecting 781 Workers

1 Mins read

By Emon Reiser

Pfizer, a leading pharmaceutical company, will be closing its facility located in Peapack, N.J. This decision will have a substantial impact on the jobs of 781 workers, as reported in a Workers Adjustment and Retraining Notification filed with the state.

Workforce Reassignments

In an effort to mitigate the impact of the closure, Pfizer has announced that many of the affected employees will be reassigned to the company’s New York headquarters at 66 Hudson Yards. Additionally, a small number of workers will be moved to Pfizer’s Parsippany, N.J., site.

Planned Closure Date

The closure of the Peapack facility is scheduled to take place on February 12, 2024. This move comes after Pfizer’s announcement in 2021 that it intends to sell the entire Peapack campus.

Deliberation and Decision

Pfizer has been carefully considering the future of the Peapack site over the past couple of years. After extensive evaluation, the decision to close the facility has been made. As a result, Pfizer has informed its colleagues that all positions at the site will be relocating to other Pfizer facilities.

Impact of Workforce Cuts

Last month, Pfizer revealed workforce cuts as it revised its revenue guidance for the year. The company had to reduce its revenue projections by $9 billion due to a decline in sales of its Covid-19 vaccine.

Related posts
News

North Korea Accused of Stealing Billions Through Cyberattacks to Fund Nuclear Program

3 Mins read
An international report reveals North Korea’s extensive cyber operations, detailing billions stolen through cryptocurrency theft, fake remote tech jobs, and malware, all…
News

The silent war: When virtual attacks inflict real-world devastation

3 Mins read
As digital transformation accelerates worldwide, cyberspace has become vital to the economy and society — but also a high-risk arena for data…
News

'Ether Caught Fire': ETH Surged as Capital Fled Bitcoin in Q3, CoinGecko Report Finds

2 Mins read
Ethereum (ETH) emerged as the frontrunner in crypto’s third-quarter recovery, leaving bitcoin (BTC) behind as capital flowed into altcoins, DeFi protocols, and…

Leave a Reply

Your email address will not be published. Required fields are marked *